MrPassiveUK
247 posts

MrPassiveUK
@MrPassiveUK
Documenting my financial journey. 700k invested. Started early and some luck in there too.
UK Katılım Mayıs 2026
347 Takip Edilen141 Takipçiler

@MsVeilMoney sorry that is a mistype! $395! i wish I got it at $378!!
English

@MsVeilMoney Well I thought it was an opportunity at $378 so maybe I am not best person to give feedback on this!
English

Anyone else think that the England band has had its day? Two songs if you can say one is a song. Let the fans do some singing of their own. #ENGCRO
English

@baileyinvests I hear you I got in at about 690! Most red position I’ve had
English

@BrummieTricky I really hope we look at premier league players. I wanted Dominic Calvert Lewis and grealish and Fernandez last year. All I believe we could have got for cheaper than what spent on unproven not premier league ready players.
English

@steady_profits I like this I’m thinking of selling $MELI completely and allocating this stock but I am happy with the price I paid for $MELI.
English

$CELH closed above the key $30 level yesterday and for technical analysis fans, it also had a large green engulfing candle on the daily price chart, which is considered to be very bullish.
So hopefully we can start pushing on towards $40+ now after basing out between $27.50 and $30 recently.
Even at this price, the company trades on a forward P/E of just 15.4 and 13.6 for 2027 and 2028, which is not a high valuation for a company that potentially has years of growth ahead of them.
Analysts generally agree too as the average target price is around double the current price at $60.57.

English

@steady_profits I have this too but my average price is 52 so some way to go for me! Whats your average in?
English

Novo Nordisk $NVO is currently the biggest pre-market gainer in my portfolio, trading 3.81% higher at $45.21.
Maybe the constant flow of good news that we have seen recently regarding regulatory approvals in the UAE and the UK for the Wegovy pill, and plans to get approved in China, is finally starting to be reflected in the share price.

James Woolley@steady_profits
The CEO of Novo Nordisk $NVO, Mike Doustdar, has revealed that the company is planning to seek regulatory approval for their oral Wegovy pill in China in the next few months. It has already been approved in the US, the United Arab Emirates and the UK, and is expected to be approved in the EU soon, so this will be another huge market for them to tap into if they do get approval in China. As always, the share price hasn't reacted much to this news, but it is at least trading a little higher pre-market at $44.21.
English

@MoInvestingHQ My entry price was $88 so still got some breathing room but man I want this to start heading north pronto
English

@ItsJamesHall 10.000 millionaires should have been multi millionaires.
English

Guys, the market crash has started 📉

MsVeil@MsVeilMoney
If you had $10,000 right now...📈 What stock are you buying in this crash? 🤔
English












